Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2023 Sep 24.
Published in final edited form as: Subst Use Misuse. 2022 Sep 24;57(13):1923–1930. doi: 10.1080/10826084.2022.2120363

Substance-Specific Risk Factors Among Young Adults: Potential Prevention Targets Across Cannabis-Permissive Environments

Katarina Guttmannova 1, Sabrina Oesterle 2, Martie L Skinner 3, Margaret R Kuklinski 4, Brittney Hultgren 5, Isaac C Rhew 6, Myra Parker 7, John S Briney 8, Helene R White 9
PMCID: PMC9701568  NIHMSID: NIHMS1846382  PMID: 36151975

Abstract

Purpose:

This study examined levels of substance-specific risk factors such as perception of harm from substance use among young adults in a range of cannabis-permissive environments. The main objective was to inform future preventive interventions aimed at reducing cannabis use in the context of increasingly permissive environments.

Methods:

Data came from the Community Youth Development Study (CYDS) collected in 2016 when participants were about 23 years old (n = 1,722 participants residing in 46 U.S. states). Young adults self-reported their perceptions about the harms related to cannabis, alcohol, and cigarette use; attitudes about and ease of access to cannabis and other substances; and perceived wrongfulness and social acceptability of cannabis, alcohol, and cigarette use and of selling of cannabis and other illegal drugs.

Results:

Young adults in more permissive cannabis contexts reported higher levels of all cannabis-specific risk factors (e.g., greater access to and more favorable attitudes about cannabis use), except for perception of harm from regular cannabis use. However, permissiveness of the cannabis environment was not associated with heightened levels of risk factors for other substance use (such as alcohol, cigarettes, and opioids).

Conclusions:

Future preventive interventions for young adults living in more permissive cannabis contexts may need to focus on cannabis-specific risk factors in particular and go beyond considerations of harm from regular use. Future studies should replicate these findings with other samples.

Keywords: cannabis, substance use, risk factors

Introduction

Cannabis use generally peaks in young adulthood, and the past two decades have seen an increase in use in this age group in the United States. Studies have shown that a typical developmental pattern for both cannabis and other substance use follows an arc that increases throughout adolescence, with a peak in the early to mid-20s and a subsequent decline in the 30s (Palmer et al., 2009; Schulenberg et al., 2019; Schuler et al., 2015). Data from national studies in the United States indicate increases in the prevalence of young adult cannabis use over the past two decades; according to the data from the National Survey of Drug Use and Health, the prevalence of past-year cannabis use among young adults ages 18 - 25 has increased by over 5% between 2002 and 2019, with more than a third (35.4%) of young adults reporting use in 2019 (Substance Abuse and Mental Health Administration, 2019). Prevention and intervention research has suggested that reducing availability and targeting malleable cannabis-specific risk factors such as perceived harm from use and favorable attitudes and norms may help to reduce use (e.g., Catalano et al., 2012). Reducing cannabis use in young adulthood can prevent serious short- and long-term health, economic, and social consequences that include addiction, respiratory and cardiovascular health complications, accidents and motor vehicle crashes, stunted academic achievement and educational attainment, and occupational underperformance (Hall et al., 2019; Volkow et al., 2014). Thus, the focus on malleable risk factors represents a public health and safety priority.

Indeed, targeting factors that increase the likelihood of health risk behaviors (i.e., risk factors) is one of the main tools of preventive efforts focused on health and well-being in general and efforts to prevent or reduce harms related to substance use in particular (Catalano et al., 2012). These efforts can be bolstered by understanding what substance-specific risk factors are elevated in what contexts, including the increasingly diverse legal contexts related to adult cannabis use. Young adults in the United States live in cannabis environments that vary substantially depending on how individual state legislatures approach restrictions on cannabis. These restrictions range from being consistent with the federal law and prohibiting and penalizing cannabis use for any purpose, to permitting medical use, decriminalizing nonmedical use, and legalizing use for nonmedical or “recreational” purposes for adults age 21 and over (for review see, e.g., Lancione et al., 2020; Pacula & Smart, 2017). The first state to legalize medical cannabis use was California in 1996, and many other states soon followed. In 2012, legalization of nonmedical cannabis use started at the state level when Washington State and Colorado voters approved statewide initiatives for the sale and use of cannabis for adults over the age of 21. Currently, more than two thirds of the U.S. population live in states where cannabis has been legalized for medical or nonmedical use (Johnson & Guttmannova, 2019), and all states that had legalized nonmedical use by 2016—when this study took place—had previously legalized medical use and decriminalized nonmedical use (Klieger et al., 2017). These changes in the legal context change access to cannabis and also shape perceptions about the acceptability of use and other beliefs, attitudes, and norms about cannabis, all of which are risk factors for use (e.g., Guttmannova, Jones, et al., 2019; Johnson & Guttmannova, 2019; Pacula & Smart, 2017).

The gradual loosening of legal restrictions on cannabis occurring in many U.S. states has sparked concerns not only about potential increases in cannabis use but also in other, often comorbid, substance use (e.g., Guttmannova, Jones, et al., 2019; Guttmannova et al., 2016; Johnson & Guttmannova, 2019; Pacula et al., 2015). Past research provides strong evidence that young adults who use cannabis are more likely to engage in alcohol, tobacco, or other substance use when compared to young adults who do not use cannabis (e.g., Palmer et al., 2009; Yurasek et al., 2017). This suggests that more permissive cannabis contexts could be associated with higher levels of risk factors not just specifically for cannabis, but for other substances as well, and effective prevention and intervention efforts aimed at reducing harmful behavior and improving health may need to include an additional focus on risk factors specific for other substances. Thus, the following two main research questions guided this study: (a) Are cannabis-specific risk factors higher among young adults who live in legally more permissive cannabis contexts? (b) Are other substance-specific risk factors (e.g., perceived harm of smoking cigarettes or drinking alcohol) also elevated in more permissive cannabis contexts?

Specifically, we examined perceptions about the harms related to cannabis; attitudes about and ease of access to cannabis; and perceived wrongfulness and social acceptability of cannabis, alcohol, and cigarette use and of selling of cannabis and other illegal drugs among young adults living in different legal cannabis contexts. Because past experience with cannabis use could influence beliefs, attitudes, and norms about cannabis use in a reciprocal manner (e.g., Guttmannova, Skinner, et al., 2019), and cannabis use may already be elevated in more permissive contexts (e.g., Pacula & Smart, 2017; Wen et al., 2015), we accounted for the prevalence of past-year use in the models assessing the association between permissiveness of the legal context and the risk factors. Other controls included sociodemographic factors associated with elevated prevalence of young adult substance use, such as sex, race/ethnicity, and education level (e.g., Banks & Zapolski, 2018; Townsend et al., 2007). We hypothesized that greater legal permissiveness toward cannabis use would predict elevated levels of cannabis-specific risk factors as well as risk factors specific to other substance use.

Methods

Sample

Data came from the Community Youth Development Study (CYDS; for a description of the study, original recruitment and sample, see Hawkins et al., 2008), a community-randomized controlled trial of the Communities That Care (CTC) prevention system originally conducted in 24 rural and small-town communities in seven states (Colorado, Illinois, Kansas, Maine, Oregon, Utah, and Washington) with first data collection occurring in 2004. The present study included young adults from the control sample only. The intervention sample was excluded because the trial showed that CTC reduced levels of risk factors and drug use in adolescence (e.g., Hawkins et al., 2014), with some intervention effects on drug use persisting into young adulthood (Oesterle et al., 2018) and the effects of the CTC intervention were not the focus of the present study. The sample is sex-balanced (52% female), with 26.6% self-identifying as Latino/a or Hispanic. In terms of race, 60.9%% self-identified as White, 2.7% as Black, 1.6% as Asian, 3.7% as Native American, 0.4% as Pacific Islander, 5.0% as multiracial, 24.7% as “other” (76.1% of participants who chose this category self-identified as Latino/a or Hispanic), and 0.9% did not answer the race question.

The data for the present study were collected in 2016 (n = 1,700; 85.3% of the active, still-living control sample) when the average age of participants was 23 years (M = 22.70; SD = 0.57) and all participants were over the age of 21, the legal age to consume alcohol and, in states where cannabis had been legalized for nonmedical or “recreational” purposes, to use cannabis.

Data were collected using the Youth Development Survey (based on the Communities That Care Youth Survey; Arthur et al., 2002) that was offered online or as a mailed paper questionnaire. Participants received completion incentives of $45 and the vast majority of participants (77%) completed the survey online. The study protocol was reviewed and approved by the University of Washington’s Human Subjects Review Committee.

Measures

The survey used the term “marijuana” in the assessment of risk factors and use without defining the term. Because participants could have interpreted the term in different ways, we use the more general and encompassing term “cannabis” in this paper.

Substance-specific risk factors.

Participants were asked about their perception of harm from using cannabis regularly and their perception of harm to children from seeing adults using cannabis in public. Response options ranged from 0 = high risk to 3 = no risk. Participants were also asked how wrong they think it is for someone their age to use cannabis and sell cannabis (0 = very wrong to 3 = not wrong at all); what the chances are that they would be seen as “cool” if they used cannabis (0 = no chance to 3 = very good chance); and how easy it would be to get some cannabis if they wanted to get it (0 = very hard to 3 = very easy). Participants were also asked about their perception of harm from smoking one or more packs of cigarettes a day, and harm from having five or more drinks of an alcoholic beverage in one occasion at least once or twice each week; how wrong it would be for someone their age to engage in these behaviors, and what were the chances they would be seen as “cool” if they engaged in these behaviors. Because alcohol and cigarette use were legal for this age group in all states, we did not assess ease of access to these two substances but did assess ease of access to prescription opioids (e.g., OxyContin, Vicodin, Percocet) and other prescription drugs (e.g., Adderall, Ritalin, Valium, Xanax) not prescribed to them by their doctor, and access to other drugs “like cocaine, LSD, or amphetamines.” We also assessed how wrong respondents thought it would be to sell drugs (other than cannabis). The response options for these questions about other substances were analogous to those asked about cannabis.

Legal permissiveness of cannabis context.

The legal permissiveness of young adults’ cannabis contexts was coded according to the legality of cannabis use in their state of residence at the time of the interview (February-October, 2016). The permissiveness of the cannabis legal context was coded on a 4-point scale ranging from 1 = not legal, 2 = legal medical, 3 = legal medical and decriminalized nonmedical, and 4 = legal medical as well as nonmedical (“recreational”). The majority (57.3%, n = 1,025) of participants resided where cannabis use was not legal, 5.4% (n = 93) where only medical cannabis use was legal, 8.2% (n = 141) in states that had legalized cannabis use for medical use and decriminalized nonmedical use, and 26.8% (n = 463) where medical and nonmedical use was legal. Six participants resided outside of the United States and were excluded from the analyses.

Covariates.

Cannabis use was based on a question about the frequency of past-year use and coded as any past-year use of cannabis (no use = 0; some use = 1). Analyses also adjusted for variation in demographic characteristics of participants and included: participant’s sex (male = 1, female = 0); race (White = 1; other = 0); whether the participant self-identified as Hispanic or Latino(a) (yes = 1, no = 0); and their highest level of education, coded as three mutually exclusive indicator variables of dropped out of high school (referent), high school only, and more than high school.

Analysis

All analyses were conducted in STATA 14.0. We estimated a series of ordered logistic regression models to examine the association between the permissiveness of the cannabis legal context and substance use-specific risk factors (outcomes). The predictors were entered in a series of steps. First, we entered the permissiveness of the context variable (Model 1), then we included the background and demographic covariates (Model 2). Past-year cannabis use was entered in the final model (Model 3) to control for the possibility that risk factors are higher due to more prevalent use in more permissive contexts. At the time of the Age 23 survey, participants were dispersed across 46 different U.S. states with little clustering within states beyond the original study states. Analyses adjusted for clustering in the original 12 study communities to reflect the study design. Specifically, all models included community indicator variables in order to control for clustering of participants in their original communities.

Results

Table 1 provides descriptive statistics of all study variables. Supplemental Tables 1 – 4 show full regression results for all three models and all outcomes. Figures 1 – 4 focus on the key association of interest by displaying adjusted odds ratios with their 95% confidence intervals from Model 3, which controlled for all covariates, including prior cannabis use. Results suggest that greater permissiveness of the cannabis legal context was significantly associated with higher levels of all cannabis-specific risk factors except for perception of harm from regular cannabis use, but not with any risk factors pertaining to other substance use.

Table 1.

Descriptive statistics for all study variables

Variables Response options %
Legal permissiveness of cannabis context not legal 59.52
legal medical 5.4
legal medical and decriminalized 8.19
legal medicl and nonmedical 26.89
Demographic covariates Male 48.03
White 61.76
Hispanic 26.1
No high school diploma 8.93
High school diploma or GED 57.04
Beyond high school diploma 34.03
Prevalence of past year cannabis use Used cannabis in past year 36.42
Perception of harm from using cannabis regularly No risk 20.09
Slight risk 28.42
Moderate risk 23.59
Great risk 27.9
Perception of harm to children from seeing adults using cannabis in public No! 8.14
no 20.88
yes 25.42
Yes! 45.55
How wrong they think it is for someone their age to use cannabis Very wrong 36.28
Wrong 13.84
Little bit wrong 17.5
Not wrong at all 32.38
How wrong they think it is for someone their age to sell cannabis Very wrong 55.78
Wrong 15.34
Little bit wrong 15.46
Not wrong at all 13.42
Chances that they would be seen as “cool” if they used cannabis No chance 47.78
Little chance 21.88
Some chance 16.92
Pretty good chance 7.93
Very good chance 5.48
How easy would it be to get some cannabis Very hard 13.7
Sort of hard 9.29
Sort of easy 20.38
Very easy 56.62
Perception of harm from smoking one or more packs of cigarettes a day No risk 2.45
Slight risk 3.9
Moderate risk 16.78
Great risk 76.86
Perception of harm from heavy and regular alcohol use 1 No risk 2.85
Slight risk 17.58
Moderate risk 36.96
Great risk 42.61
How wrong it would be for someone their age to smoke one or more packs of cigarettes a day Very wrong 50.84
Wrong 22.2
Little bit wrong 15.46
Not wrong at all 11.5
How wrong it would be for someone their age to engage in heavy and regular alcohol use 1 Very wrong 39.3
Wrong 19.65
Little bit wrong 23.49
Not wrong at all 17.56
Chances they would be seen as “cool” if they smoked one or more packs of cigarettes a day No chance 65.13
Little chance 25.36
Some chance 6.82
Pretty good chance 1.63
Very good chance 1.05
Chances they would be seen as “cool” if they engaged in heavy and regular alcohol use 1 No chance 42.77
Little chance 25.93
Some chance 19.46
Pretty good chance 8.92
Very good chance 2.91
Ease of access to prescription opioids (e.g., OxyContin, Vicodin, Percocet) not prescribed by their doctor Very hard 35.62
Sort of hard 27.37
Sort of easy 20.63
Very easy 16.39
Ease of access to other prescription drugs not prescribed by their doctor Very hard 34.07
Sort of hard 25.58
Sort of easy 21.8
Very easy 18.55
Ease of access to other drugs “like cocaine, LSD, or methamphetamines” Very hard 35.74
Sort of hard 25.9
Sort of easy 22.41
Very easy 15.95
How wrong it would be to sell drugs (other than cannabis) Very wrong 77.89
Wrong 13.55
Little bit wrong 6.81
Not wrong at all 1.75

Notes: GED=General Educational Development diploma;

1

five or more drinks of alcohol in one occasion weekly or more often.

Figure 1.

Figure 1.

Adjusted odds ratios and 95% confidence intervals around the odds ratios from ordered logistic regressions estimating associations between legal permissiveness of cannabis context and perception of easy access to different substances.

Figure 4.

Figure 4.

Adjusted odds ratios and 95% confidence intervals around the odds ratios from ordered logistic regressions estimating associations between legal permissiveness of cannabis context and perception of harm from using different substances.

More specifically, as indicated in Figure 1 and supplemental Table 1, controlling for the aforementioned covariates, there was a significant positive association between permissiveness of context and perceived availability of cannabis (OR = 1.31; 95% CI = [1.11; 1.54]; p = 0.002), but not other illegal drugs, prescription opioids, or other prescription drugs. Similarly, there was a positive association between permissiveness of cannabis legal context and (a) the belief that cannabis use would make them “look cool” (OR = 1.18; 95% CI = [1.03; 1.36]; p = 0.021; see Figure 2 and supplemental Table 2); (b) the belief it is not wrong to use cannabis (OR = 1.16; 95% CI = [1.00; 1.36]; p = 0.049; see Figure 3 and supplemental Table 3); (c) the belief it is not wrong to sell cannabis (OR = 1.28; 95% CI = [1.10; 1.50]; p = 0.002; see Figure 3 and supplemental Table 3); and (d) perception of harm to children from seeing adults using cannabis in public (OR = 1.22; 95% CI = [1.05; 1.40]; p = 0.007; see Figure 4 and supplemental Table 4). However, and contrary to our hypotheses, the association between the permissiveness of cannabis context and the perception of harmfulness of regular substance use was not statistically significant for cannabis use nor the use of alcohol and cigarettes (see Figure 4 and supplemental Table 4).

Figure 2.

Figure 2.

Adjusted odds ratios and 95% confidence intervals around the odds ratios from ordered logistic regressions estimating associations between legal permissiveness of cannabis context and favorable attitudes toward substance use (seen as “cool” if engaging in…).

Figure 3.

Figure 3.

Adjusted odds ratios and 95% confidence intervals around the odds ratios from ordered logistic regressions estimating associations between legal permissiveness of cannabis context and favorable attitudes toward substance use (“How wrong would it be for someone your age to…”).

Discussion

The legal and social environment has become increasingly permissive toward cannabis use over the last two decades. This study examined associations between beliefs, attitudes, and perceptions about cannabis as well as other substances and the permissiveness of the cannabis legal context in which young adults resided in order to inform future preventive interventions for substance use among young adults. The main findings of this study are that young adults who were living in legally more permissive cannabis contexts, indeed, were more likely to report more approving beliefs, attitudes, and perceptions towards cannabis, but not toward other substances, including alcohol and tobacco. These findings are consistent with reports of increased presence of cannabis-related advertising and pro-cannabis public messaging in more permissive cannabis contexts (e.g., Fiala et al., 2018) and studies that have reported a positive association between pro-cannabis media presence and cannabis-specific risk factors and use among adolescents (e.g., D’Amico et al., 2015; Fiala et al., 2020) as well as young adults (e.g., Krauss et al., 2017).

While perception of harm to children from seeing adults using cannabis in public was positively associated with the permissiveness of the legal context, perception of harm from using cannabis regularly was not. This finding is unexpected given reports of increasing likelihood that young adults perceive no or low health risk related to cannabis use in more permissive cannabis environments, such as where medical cannabis has been legalized (Wen et al., 2019). The lack of a statistically significant association between the permissiveness of the legal context and perception of harm from regular use in our study could reflect a general trend towards decreased perception of harm from cannabis use nationwide, even where cannabis laws have not become more permissive (Schulenberg et al., 2020). Continuing to focus prevention and intervention efforts on perceptions of harm from regular cannabis use no matter the legal context may, therefore, be advised. The prevalence of alcohol and cigarette use among young adults has been declining nationally in recent years (Substance Abuse and Mental Health Administration, 2019) and may be a consequence of longstanding public health campaigns that clearly communicate harms from cigarettes (e.g., Bala et al., 2017; Dilley et al., 2012) and regular alcohol use (e.g., Young et al., 2018).

Although the results of this study suggest that greater permissiveness of cannabis legal context is associated with higher levels of cannabis-specific risk factors among young adults, the good news is that this increase does not extend to risk factors specific to other substances, such as favorable attitudes toward alcohol and tobacco use. However, an increase in cannabis-specific risk factors may impact other substance use indirectly as studies have documented complementary relationships between cannabis, alcohol, and tobacco use as well as positive associations between substance-specific risk factors for different substances (e.g., Jones et al., 2019). Such associations suggest that increases in cannabis use could be associated with increases in other substance use (e.g., Guttmannova et al., 2016). In the context of increasing legal permissiveness of cannabis across the nation, the findings of this study point to the importance of prevention and intervention efforts for young adults that focus specifically on reducing cannabis-specific risk factors.

Limitations and Directions for Future Research

The present study has some limitations and the findings should be interpreted with these in mind. First, while we controlled for past-year cannabis use in our models of association between cannabis legal context and cannabis-specific risk factors, the reports are cross-sectional and future studies could incorporate both concurrent and reciprocal associations between risk and use in order to understand their dynamic interplay. Next, this study did not evaluate the impact of state-level cannabis policies at a broad, population-level, aggregate impacts, but instead examined the association between self-reported substance use risk factors and the permissiveness of that person’s particular context. This constitutes a novel way of examining the role of broad societal changes in individuals’ lives but precludes making conclusions about the effects of cannabis policy changes on outcomes. Similarly, there was temporal variability in the length of period when cannabis was legalized in different jurisdictions and this study was not designed to capture it. Future studies, particularly those focusing on the effects of cannabis policy changes on outcomes, could zoom in on the effect that length of legality in different jurisdictions may have on young adults’ attitudes and related factors. Along those lines, studies that account for the possibility that cannabis-related risk factors such as favorable attitudes toward cannabis might already be elevated in jurisdictions that eventually implement cannabis policy change would be particularly informative. Enforcement of cannabis laws, which was not included in this analysis, may vary by jurisdiction (Ward et al., 2018), and has been shown to disproportionately impact people and communities of color and those with socioeconomic disadvantage (Stohr et al., 2020). These factors could also contribute to perceptions and beliefs about cannabis. Future studies, particularly those designed to evaluate the effect of changes in cannabis policy on risk factors and use, could focus specifically on the implementation of legalization with more targeted samples. Next, the study’s sample consisted of young adults who grew up in rural and small towns in seven states in the West, Midwest, and Northeast regions of the United States. Although they lived in 46 out of 50 U.S. states by the time they reached young adulthood, the original locations from which the sample was drawn may limit generalizability of the findings.

Conclusions

The findings from this study suggest that future preventive interventions for cannabis use for young adults who live in legally more permissive cannabis contexts should (a) be cannabis-specific; and (b) go beyond targeting harm of regular cannabis use to also include other perceptions, norms, and beliefs about cannabis use. For example, more permissive cannabis contexts provide opportunities for education and prevention and intervention efforts focused on risk factors such as perception of harm to children from seeing adults using cannabis in public. While risk factors specific to other substances were not elevated in more legally permissive cannabis contexts—an encouraging finding—epidemiologic studies should continue to monitor their levels to ensure continued appropriate tailoring of preventive interventions aimed at reducing harm from substance use.

Supplementary Material

Supp 1

Acknowledgments and Funding

This study was supported by the National Institute on Drug Abuse of the National Institutes of Health under grant numbers R01DA015183, R56DA044522, and R01DA044522, with co-funding from the National Cancer Institute, the National Institute of Child Health and Human Development, the National Institute of Mental Health, the Center for Substance Abuse Prevention, and the National Institute on Alcohol Abuse and Alcoholism. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. These organizations had no further role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication. ClinicalTrials.gov identifier: NCT01088542.

The authors gratefully acknowledge CYDS panel participants for their contribution to this study, the Social Development Research Group (SDRG) Survey Research Division for their hard work collecting data, Ms. Elena Riederer for her assistance with preparation of the early draft of this manuscript, and Ms. Tanya Williams and Ms. Diane Christiansen for their editorial and administrative support.

Footnotes

Disclosure of interest. The authors report no conflict of interest.

An earlier version of this paper was presented at the annual meeting of the Society for Prevention Research held May 28-31, 2019, in San Francisco, CA.

Contributor Information

Katarina Guttmannova, Center for the Study of Health and Risk Behavior, Department of Psychiatry and Behavioral Sciences, University of Washington, 1100 NE 45th St., Suite 300, Seattle WA 98105

Sabrina Oesterle, Southwest Interdisciplinary Research Center, School of Social Work, Arizona State University, 201 N. Central Ave, 33rd Floor, Phoenix, AZ 85004

Martie L. Skinner, Social Development Research Group, School of Social Work, University of Washington, 9725 3rd Ave. NE, Suite 401, Seattle, WA 98115

Margaret R. Kuklinski, Social Development Research Group, School of Social Work, University of Washington, 9725 3rd Ave. NE, Suite 401, Seattle, WA 98115

Brittney Hultgren, Center for the Study of Health and Risk Behavior, Department of Psychiatry and Behavioral Sciences, University of Washington, 1100 NE 45th St., Suite 300, Seattle WA 98105

Isaac C. Rhew, Center for the Study of Health and Risk Behavior, Department of Psychiatry and Behavioral Sciences, University of Washington, 1100 NE 45th St., Suite 300, Seattle WA 98105

Myra Parker, Center for the Study of Health and Risk Behavior, Department of Psychiatry and Behavioral Sciences, University of Washington, 1100 NE 45th St., Suite 300, Seattle WA 98105

John S. Briney, Social Development Research Group, School of Social Work, University of Washington, 9725 3rd Ave. NE, Suite 401, Seattle, WA 98115.

Helene R. White, Distinguished Professor Emerita at Rutgers University, Center of Alcohol and Substance Studies, 607 Allison Road, Piscataway, NJ 08854

References

  1. Arthur MW, Hawkins JD, Pollard JA, Catalano RF, & Baglioni AJ Jr., (2002). Measuring risk and protective factors for substance use, delinquency, and other adolescent problem behaviors: The Communities That Care Youth Survey. Evaluation Review, 26(6), 575–601. 10.1177/0193841X0202600601 [DOI] [PubMed] [Google Scholar]
  2. Bala MM, Strzeszynski L, & Topor-Madry R (2017). Mass media interventions for smoking cessation in adults. Cochrane Database of Systematic Reviews, 11(11), Cd004704. 10.1002/14651858.CD004704.pub4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Banks DE, & Zapolski TCB (2018). The crossover effect: A review of racial/ethnic variations in risk for substance use and substance use disorder across development. Current Addiction Reports, 5(3), 386–395. 10.1007/s40429-018-0220-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Catalano RF, Fagan AA, Gavin LE, Greenberg MT, Irwin CE, Ross DA, & Shek DTL (2012). Worldwide application of prevention science in adolescent health. The Lancet, 379(9826), 1653–1664. 10.1016/S0140-6736(12)60238-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. D’Amico EJ, Miles JN, & Tucker JS (2015). Gateway to curiosity: Medical marijuana ads and intention and use during middle school. Psychology of Addictive Behaviors, 29(3), 613–619. 10.1037/adb0000094 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dilley JA, Harris JR, Boysun MJ, & Reid TR (2012). Program, policy, and price interventions for tobacco control: Quantifying the return on investment of a state tobacco control program. American Journal of Public Health, 102(2), e22–28. 10.2105/ajph.2011.300506 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fiala SC, Dilley JA, Everson EM, Firth CL, & Maher JE (2020). Youth exposure to marijuana advertising in Oregon’s legal retail marijuana market. Preventing Chronic Disease, 17, E110. 10.5888/pcd17.190206 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fiala SC, Dilley JA, Firth CL, & Maher JE (2018). Exposure to marijuana marketing after legalization of retail sales: Oregonians’ experiences, 2015-2016. American Journal of Public Health, 108(1), 120–127. 10.2105/ajph.2017.304136 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Guttmannova K, Jones AA, Johnson JK, Oesterle S, Johnson RM, & Martins SS (2019). Using existing data to advance knowledge about adolescent and emerging adult marijuana use in the context of changes in marijuana policies Prevention Science, 20(2), 291–299. 10.1007/s11121-019-00991-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Guttmannova K, Lee C, Kilmer JR, Fleming CB, Rhew IC, Kosterman R, & Larimer ME (2016). Impacts of changing marijuana policies on alcohol and other drug use in the United States. Alcoholism: Clinical and Experimental Research, 40(1), 33–46. 10.1111/acer.12942 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Guttmannova K, Skinner ML, Oesterle S, White HR, Catalano RF, & Hawkins JD (2019). The interplay between marijuana-specific risk factors and marijuana use over the course of adolescence. Prevention Science, 20(2), 235–245. 10.1007/s11121-018-0882-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hall W, Stjepanović D, Caulkins J, Lynskey M, Leung J, Campbell G, & Degenhardt L (2019). Public health implications of legalising the production and sale of cannabis for medicinal and recreational use. The Lancet, 394(10208), 1580–1590. 10.1016/s0140-6736(19)31789-1 [DOI] [PubMed] [Google Scholar]
  13. Hawkins JD, Catalano RF, Arthur MW, Egan E, Brown EC, Abbott RD, & Murray DM (2008). Testing Communities That Care: The rationale, design and behavioral baseline equivalence of the Community Youth Development Study. Prevention Science, 9(3), 178–190. 10.1007/s11121-008-0092-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hawkins JD, Oesterle S, Brown EC, Abbott RD, & Catalano RF (2014). Youth problem behaviors 8 years after implementing the Communities That Care prevention system. A community-randomized trial. JAMA Pediatrics, 168(2), 122–129. 10.1001/jamapediatrics.2013.4009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Johnson RM, & Guttmannova K (2019). Marijuana use among adolescents and emerging adults in the midst of policy change: Introduction to the special issue. Prevention Science, 20(2), 179–184. 10.1007/s11121-019-0989-7 [DOI] [PubMed] [Google Scholar]
  16. Jones TM, Epstein M, Hill KG, Bailey JA, & Hawkins JD (2019). General and specific predictors of comorbid substance use and internalizing problems from adolescence to age 33. Prevention Science, 20(5), 705–714. 10.1007/s11121-018-0959-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Klieger SB, Gutman A, Allen L, Pacula RL, Ibrahim JK, & Burris S (2017). Mapping medical marijuana: State laws regulating patients, product safety, supply chains and dispensaries, 2017. Addiction, 112(12), 2206–2216. 10.1111/add.13910 [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Krauss MJ, Sowles SJ, Sehi A, Spitznagel EL, Berg CJ, Bierut LJ, & Cavazos-Rehg PA (2017). Marijuana advertising exposure among current marijuana users in the U.S. Drug and Alcohol Dependence, 174, 192–200. 10.1016/j.drugalcdep.2017.01.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lancione S, Wade K, Windle SB, Filion KB, Thombs BD, & Eisenberg MJ (2020). Non-medical cannabis in North America: An overview of regulatory approaches. Public Health, 178, 7–14. 10.1016/j.puhe.2019.08.018 [DOI] [PubMed] [Google Scholar]
  20. Oesterle S, Kuklinski MR, Hawkins JD, Skinner ML, Guttmannova K, & Rhew IC (2018). Long-term effects of the Communities That Care trial on substance use, antisocial behavior, and violence through age 21 years. American Journal of Public Health, 108(5), 659–665. 10.2105/AJPH.2018.304320 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Pacula RL, Powell D, Heaton P, & Sevigny EL (2015). Assessing the effects of medical marijuana laws on marijuana use: The devil is in the details. Journal of Policy Analysis and Management, 34(1), 7–31. 10.1002/pam.21804 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Pacula RL, & Smart R (2017). Medical marijuana and marijuana legalization. Annual Review of Clinical Psychology, 13, 397–419. 10.1146/annurev-clinpsy-032816-045128 [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Palmer RHC, Young SE, Hopfer CJ, Corley RP, Stallings MC, Crowley TJ, & Hewitt JK (2009). Developmental epidemiology of drug use and abuse in adolescence and young adulthood: Evidence of generalized risk. Drug and Alcohol Dependence, 102(1), 78–87. 10.1016/j.drugalcdep.2009.01.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Schulenberg JE, Johnston LD, O’Malley PM, Bachman JG, Miech RA, & Patrick ME (2019). Monitoring the Future national results on drug use, 1975-2018: Volume II: College students and adults ages 19-60. Ann Arbor, MI: Institute for Social Research, The University of Michigan. Retrieved from http://monitoringthefuture.org/pubs/monographs/mtf-vol2_2017.pdf [Google Scholar]
  25. Schulenberg JE, Johnston LD, O’Malley PM, Bachman JG, Miech RA, & Patrick ME (2020). Monitoring the Future national results on drug use, 1975-2019: Volume II: College students and adults ages 19-60. Ann Arbor, MI: Institute for Social Research, The University of Michigan. Retrieved from http://monitoringthefuture.org/pubs.html#monographs [Google Scholar]
  26. Schuler MS, Vasilenko SA, & Lanza ST (2015). Age-varying associations between substance use behaviors and depressive symptoms during adolescence and young adulthood. Drug and Alcohol Dependence, 157, 75–82. 10.1016/j.drugalcdep.2015.10.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Stohr MK, Willits DW, Makin DA, Hemmens C, Lovrich NP, Stanton DL Sr., & Meize M (2020). Effects of marijuana legalization on law enforcement and crime: Final report. Pullman, WA: Department of Criminal Justice and Criminology, Washington State University. Retrieved November 5, 2020 from https://www.ncjrs.gov/pdffiles1/nij/grants/255060.pdf [Google Scholar]
  28. Substance Abuse and Mental Health Administration. (2019). Table 7.1A – Types of illicit drug, tobacco product, and alcohol use in lifetime among persons aged 12 or older: Numbers in thousands, 2002-2019. Retrieved from https://www.samhsa.gov/data/sites/default/files/reports/rpt29394/NSDUHDetailedTabs2019/NSDUHDetTabsSect7pe2019.htm
  29. Townsend L, Flisher AJ, & King G (2007). A systematic review of the relationship between high school dropout and substance use. Clinical Child and Family Psychology Review, 10(4), 295–317. 10.1007/s10567-007-0023-7 [DOI] [PubMed] [Google Scholar]
  30. Volkow ND, Baler RD, Compton WM, & Weiss SR (2014). Adverse health effects of marijuana use. New England Journal of Medicine, 370(23), 2219–2227. 10.1056/NEJMra1402309 [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Ward KC, Lucas PA, & Murphy A (2018). The impact of marijuana legalization on law enforcement in states surrounding Colorado. Police Quarterly, 22(2), 217–242. 10.1177/1098611118819902 [DOI] [Google Scholar]
  32. Wen H, Hockenberry JM, & Cummings JR (2015). The effect of medical marijuana laws on adolescent and adult use of marijuana, alcohol, and other substances. Journal of Health Economics, 42, 64–80. 10.1016/j.jhealeco.2015.03.007 [DOI] [PubMed] [Google Scholar]
  33. Wen H, Hockenberry JM, & Druss BG (2019). The effect of medical marijuana laws on marijuana-related attitude and perception among US adolescents and young adults. Prevention Science, 20(2), 215–223. 10.1007/s11121-018-0903-8 [DOI] [PubMed] [Google Scholar]
  34. Young B, Lewis S, Katikireddi SV, Bauld L, Stead M, Angus K, Campbell M, Hilton S, Thomas J, Hinds K, Ashie A, & Langley T (2018). Effectiveness of mass media campaigns to reduce alcohol consumption and harm: A systematic review. Alcohol and Alcoholism, 53(3), 302–316. 10.1093/alcalc/agx094 [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Yurasek AM, Aston ER, & Metrik J (2017). Co-use of alcohol and cannabis: A review. Current Addiction Reports, 4(2), 184–193. 10.1007/s40429-017-0149-8 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supp 1

RESOURCES